The drug, which is meant to treat Type 2 diabetes, was compared with Novo Nordisk’s oral semaglutide, and showed greater ...

Plan is part of the drugmaker’s pledge to bolster its domestic medicine production with four new pharmaceutical manufacturing ...

Eli Lilly said on Tuesday it will invest $5 billion to build a manufacturing facility in Virginia, part of the drugmaker's ...

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, but ...

Eli Lilly's international president said on Wednesday it was too early to assume the company would use the U.S. Food and Drug ...

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...

The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom.

Eli Lilly (LLY) stock is in focus as its popular GLP-1 med Mounjaro hits main goals in a Phase 3 trial for children and ...

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...

Drug maker Eli Lilly & Co. intends to build a $5 billion manufacturing site in Goochland County, the company announced ...

Novo Nordisk A/S rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly & Co.’s older drug Trulicity ...

Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid ...